Open Access

Characterization of AcrD, a Resistance-Nodulation-Cell Division-type multidrug efflux pump from the fire blight pathogen Erwinia amylovora

BMC Microbiology201414:13

DOI: 10.1186/1471-2180-14-13

Received: 30 September 2013

Accepted: 3 January 2014

Published: 21 January 2014

Abstract

Background

Multidrug efflux pumps are membrane translocases that have the ability to extrude a variety of structurally unrelated compounds from the cell. AcrD, a resistance-nodulation-cell division (RND) transporter, was shown to be involved in efflux of highly hydrophilic aminoglycosides and a limited number of amphiphilic compounds in E. coli. Here, a homologue of AcrD in the plant pathogen and causal agent of fire blight disease Erwinia amylovora was identified.

Results

The substrate specificity of AcrD was studied by overexpression of the corresponding gene from a high-copy plasmid in E. amylovora Ea1189-3, which is hypersensitive to many drugs due to a deficiency of the major multidrug pump AcrB. AcrD mediated resistance to several amphiphilic compounds including clotrimazole and luteolin, two compounds hitherto not described as substrates of AcrD in enterobacteria. However, AcrD was not able to expel aminoglycosides. An acrD mutant exhibited full virulence on apple rootstock and immature pear fruits. RT-PCR analysis revealed an induction of acrD expression in infected apple tissue but not on pear fruits. Moreover, a direct binding of BaeR, the response regulator of the two-component regulatory system BaeSR, to the acrD promoter was observed as has already been shown in other enterobacteria.

Conclusions

AcrD from E. amylovora is involved in resistance to a limited number of amphiphilic compounds, but in contrast to AcrD of E. coli, it is not involved in resistance to aminoglycosides. The expression of acrD was up-regulated by addition of the substrates deoxycholate, naringenin, tetracycline and zinc. AcrD appears to be regulated by the BaeSR two-component system, an envelope stress signal transduction pathway.

Keywords

Plant pathogen Fire blight Erwinia amylovora Multidrug efflux RND transporter AcrD

Background

Erwinia amylovora is the causative agent of fire blight, a destructive, contagious disease of apple, pear, and other rosaceous plants [1]. All aerial parts of the hosts can be infected by the pathogen. E. amylovora enters its host plants through natural openings (e.g., flower nectaries or leaf stomata) and wounds [2]. Upon entry, the fire blight pathogen moves through intercellular spaces towards the xylem [3]. Typical symptoms include flower necrosis, immature fruit rot, shoot curvature (shepherd’s crook), bacterial ooze secretion, and cankers on woody tissues [1]. The most effective method to treat infected plants is pruning to remove all infected tissue.

However, fire blight can infect entire orchards within a single growing season leading to devastating economic losses [4]. Presently, there are no effective therapeutics available to cure fire blight and therefore prevention is considered the best solution to manage this plant disease. Current control efforts are rather rare and rely primarily on antibiotic applications (e.g., streptomycin or oxytetracycline) to protect flowers. However, the use of antibiotics for the management of fire blight is highly controversial due to the potential risk of promoting the emergence and spread of antibiotic resistance [5].

Gram-negative bacteria often possess multidrug efflux transporters within the cytoplasmic membrane, which have been found to recognize and expel a broad range of structurally unrelated compounds from the cell [6, 7]. Among the multidrug efflux pumps, members of the resistance-nodulation-cell division (RND) family appear to be the most effective efflux systems in Gram-negative bacteria. RND transporters form a tripartite complex, consisting of an inner membrane pump that recognizes and captures the substrates, a periplasmic membrane fusion protein (MFP) and an outer membrane channel [8, 9].

AcrAB is the major multidrug efflux pump in E. coli and shows high conservation among Gram-negative bacteria [8, 1012]. AcrD, a close homolog of AcrB, is an RND-type efflux pump characterized as a transporter of aminoglycosides, a highly hydrophilic class of molecules, and as a transporter of several amphiphilic compounds [13, 14]. Typically, the inner membrane pump and the periplasmic MFP are co-transcribed in tandem on polycistronic mRNA molecules [15]. Interestingly, this is not the case for acrD, which appears as a single gene and seemingly functions in concert with AcrA, a MFP co-transcribed with AcrB [14].

Both AcrAB and AcrD efflux systems are also present in the plant pathogen E. amylovora. AcrAB has already been characterized as an efflux system required for virulence of E. amylovora in resistance towards apple phytoalexins and for successful colonization of the host plant [16]. AcrAB of E. amylovora showed a similar substrate spectrum as AcrAB of E. coli[17]. In this study, the substrate specificity of AcrD from E. amylovora was characterized and its contribution to virulence in apple and pear analyzed. As it was found that acrD is expressed only at low levels under in vitro conditions, we were interested in investigating whether the expression of the AcrD transporter in E. amylovora is induced in planta.

Multidrug transporters are often expressed under control of local, as well as, global transcriptional regulators [18]. Current data show that expression of acrD in E. coli can be induced by the two-component regulatory system BaeSR [19]. Two-component systems (TCS) play an important role in the regulation of physiological processes in response to environmental or cellular parameters and enable bacterial cells to adapt to changing environmental conditions. TCSs typically consist of a membrane-bound histidine protein kinase (HPK) whose autokinase activity is dependent upon sensing a specific environmental stimulus (e.g., nutrients, temperature, pH, toxins or oxidative stress) [20]. The second protein of a TCS is a response regulator, onto which a phosphoryl group is transferred from the phosphorylated HPK, and which functions as a phosphorylation-activated switch that regulates output responses within the cell causing changes in the expression of target genes [21, 22].

BaeSR is a TCS that responds cell envelope damages in E. coli[23]. The small core regulon of BaeSR includes the RND-type transporters AcrD and MdtABC and the periplasmic chaperone Spy [24]. The presence of a homologous BaeSR system in E. amylovora, prompted us to analyze the impact of the response regulator BaeR on the expression levels of acrD.

Herein, we report that overexpression of the RND pump AcrD in an acrB-deficient mutant leads to increased resistance to two substrates, clotrimazole and luteolin, previously not described as substrates of AcrD in other enterobacteria. In order to determine the promoter activity in vitro, we utilized a transcriptional fusion of the promoter regions of acrAB and acrD, respectively, with the reporter gene egfp. We demonstrate that the response regulator BaeR is able to bind to the upstream region of acrD in E. amylovora Ea1189 and to induce acrD expression. Furthermore, we show that the inactivation of the RND pump AcrD did not result in reduction of virulence of E. amylovora on host plants.

Results

Identification of an acrD homologue in E. amylovora Ea1189

A search with the BLASTP program (NCBI) using the amino acid sequence of AcrD from E. coli K-12 as the query (accession number P24177) identified a homologous sequence in the genome of E. amylovora CFBP1430 (GenBank:EAMY_2508, annotated as cmeB). The annotated protein EAMY_2508 is 18 amino acids shorter at the N-terminus than the AcrD protein of E. coli. Comparison of the acrD gene sequences from E. coli and E. amylovora suggests that the EAMY_2508 gene of E. amylovora CFBP1430 has been annotated with a wrong start codon. Sequence analysis revealed an alternative ATG start codon 54 bp upstream of the annotated EAMY_2508 gene. The 18 amino acids, encoded by the 54 additional nucleotides, are 100% identical to the N-terminal region of AcrD from E. coli.

We used the genome sequence of E. amylovora CFBP1430 to design primers to PCR amplify the respective region from the genomic DNA of our model strain E. amylovora Ea1189 whose genome sequence is not yet available. The nucleotide sequence of acrD and its upstream region from E. amylovora Ea1189 show 100% identity to EAMY_2508 and its upstream region from E. amylovora CFBP1430 based on our sequencing results. AcrD is a member of the RND superfamily of transporters belonging to the Hydrophobe/Amphiphile Efflux-1 (HAE1) family (Transporter Classification Database TC #2.A.6.2.7).

A BLASTP search (NCBI) of the deduced AcrD sequence from E. amylovora Ea1189 as query identified homologous multidrug efflux transporters with high degree of sequence identity (78 - 95%) in several members of the Enterobacteriaceae family (see Additional file 1 for a phylogenetic tree).

A sequence alignment between AcrD from E. amylovora Ea1189 and AcrD from E. coli K-12 showed that the proteins share 79% identity and 89% similarity with each other (see Additional file 2). Substituted amino acids were distributed throughout the sequence, but they were at least 40% conserved (all substitutions show a physico-chemical score of minimum 4) [2528] and no insertion or deletion was observed.

Analysis of the up- and downstream regions flanking the acrD homologues from E. amylovora, E. coli and S. enterica revealed several differences (see Additional file 3) including the two-component system NarQP located upstream of acrD in E. amylovora. This system is involved in the regulation of anaerobic nitrate/nitrite respiration, and consists of the sensor kinase NarQ and the response regulator NarP. In E. coli and S. enterica, only the sensor kinase NarQ is present upstream of acrD. The response regulator NarP is situated at different positions in the genomes of E. coli and S. enterica. Moreover, the sizes of the NarQ homologues are also disparate. NarQ of E. amylovora Ea1189 is a protein consisting of 328 amino acids, whereas the NarQ homologues of E. coli and S. enterica consist of 566 amino acids.

The downstream region of acrD of E. amylovora Ea1189 contains an insertion of about 1.5 kb encoding several small hypothetical proteins.

Transmembrane organization of AcrB and AcrD in E. amylovora

In a previous study, the transmembrane organization of AcrB and AcrD from E. coli was analyzed in silico, with 12 transmembrane-spanning domains (TMD) and 2 large periplasmic loops predicted in both proteins [14]. A similar approach was accomplished with AcrB and AcrD from E. amylovora Ea1189 using the online tool TOPCONS [29]. Topology analysis predicted the typical 12 TMDs and 2 periplasmic loops between TMD1 and 2 and TMD 7 and 8 for the RND-type efflux pumps AcrB and AcrD from E. amylovora Ea1189 (see Additional file 4).

Phenotypic characterization of the acrD mutant

To evaluate the role of AcrD in antibiotic resistance and to identify substrates of this RND-type efflux pump, susceptibility tests of the wild type and the acrD mutant to a variety of antimicrobial agents were performed. Deletion of acrD resulted in no significant changes in sensitivity to tested aminoglycosides, dyes or detergents. However, the acrD mutant was 2-fold more sensitive to nitrofurantoin, erythromycin, silver nitrate and sodium tungstate in comparison to the wild type (Table 1). The differences in sensitivity were minor but reproducible. Complementation of the acrD mutant with plasmid pBlueKS.acrD, which carried the acrD gene of Ea1189 under control of the P lac , restored resistance to all tested antimicrobials (data not shown).
Table 1

Antimicrobial susceptibility profiles from an E. amylovora wild-type strain, acrD mutant, acrB mutant complemented with AcrD-overexpression plasmids pBlueSK.acrD ( acrD under control of P lac ) and pBlueKS.acrD-ext ( acrD under control of P lac and its native promoter P acrD ) and acrB mutant complemented with control plasmid pBlueSK.acrD ( acrD in opposite orientation to P lac )

Drug

MIC (μg/ml) a

 

Ea1189

Ea1189.acrD

Ea1189-3 (pBlueSK.acrD)

Ea1189-3 (pBlueKS.acrD)

Ea1189-3 (pBlueKS.acrD-ext)

   

Plac < < acrD

Plac> > acrD

Plac, PacrD> > acrD

Antimicrobials

     

Benzalkonium chloride

12.5

12.5

1.2

1.2

ND

Chloramphenicol

3.1

ND

1.2

1.2

1.2

Clotrimazole

> 1000

> 1000

6.2

12.5

25

Fusaric acid

500

500

500

500

500

Fusidic acid

250

250

3.1

6.2

25

Genistein

> 5000

> 5000

62.5

62.5

62.5

Josamycin

125

125

3.1

3.1

3.1

Luteolin

> 5000

> 5000

15.63

15.6

125

Naladixic acid

2.5

2.5

1.2

1.2

1.2

Naringenin

5000

5000

312

312

312

Nitrofurantoin

25

12.5

12.5

12.5

12.5

Norfloxacin

0.63

0.63

0.03

0.03

0.03

Novobiocin

250

250

6.2

25

100

Phloretin

5000

5000

625

625

625

Rifampicin

12.5

12.5

12.5

12.5

12.5

Tetracycline

1.5

1.5

1.2

1.2

1.2

Aminoglycosides

     

Amikacin

2.5

2.5

2.5

2.5

2.5

Gentamicin

2.5

2.5

2.5

2.5

2.5

Hygromycin B

100

100

62.5

125

125

Streptomycin

2.5

2.5

2.5

2.5

2.5

Tobramycin

2.5

2.5

2.5

2.5

2.5

Macrolids

     

Azithromycin

0.31

0.31

0.63

0.63

0.63

Clarithromycin

0.31

0.31

0.31

0.31

0.31

Erythromycin

0.63

0.31

0.16

0.16

0.16

Roxithromycin

1.25

1.25

0.16

0.16

0.16

Heavy metals

     

Cadmium acetate

12.5

12.5

25

50

50

Cobalt (II) chloride

625

625

1250

1250

1250

Copper (II) sulfate

1250

1250

1250

1250

1250

Nickel (II) chloride

1250

1250

2500

2500

2500

Silver nitrate

12.5

6.2

6.2

6.2

6.2

Sodium tungstate

125000

62500

125000

125000

125000

Zinc sulfate

156

156

156

312

312

Dyes

     

Acriflavine

50

50

6.2

6.2

6.2

Crystal violet

3.1

3.1

2.5

2.5

2.5

Ethidium bromide

250

250

3.1

3.1

6.2

Rhodamine 6G

> 100

> 100

3.1

3.1

3.1

Detergents

     

Bile salt

5000

5000

625

1250

5000

Deoxycholate

> 1000

> 1000

312

1250

2500

SDS

> 1000

> 1000

62.5

125

125

a MIC values were determined by the 2-fold dilution assay in three or more independent experiments with similar results. Boldface numbers indicate a higher or lower MIC. ND, not determined.

Expression of acrD in an acrB-deficient mutant of E. amylovora

To investigate the substrate specificity of AcrD from Ea1189, overexpression of the corresponding gene from a high-copy plasmid was achieved in E. amylovora mutant Ea1189-3, which is hypersensitive to many drugs due to a deficiency of the major multidrug efflux pump AcrB [16]. Three overexpression plasmids were generated: pBlueKS.acrD, expressing acrD under control of the lac promoter (Plac), pBlueSK.acrD-ext, expressing acrD under control of its native promoter (PacrD) and pBlueKS.acrD-ext, expressing acrD under control of both promoters Plac and PacrD. As a control, a promoterless acrD gene was cloned in the opposite direction of Plac. These plasmids were mobilized into the acrB-deficient mutant Ea1189-3 and the sensitivity of the transformants to various substrates were determined (Table 1). Ea1189-3(pBlueKS.acrD), expressing acrD under control of Plac, exhibited elevated resistance to clotrimazole (2-fold), fusidic acid (2-fold), novobiocin (4-fold), hygromycin B (2-fold), cadmium acetate (2-fold), zinc sulfate (2-fold), bile salt (2-fold), deoxycholate (4-fold), and SDS (2-fold). The expression of acrD under control of its native promoter in Ea1189-3 showed an increase in resistance similar to that of Plac-controlled acrD expression (data not shown). When acrD was under control of both promoters, Plac and PacrD, it conferred elevated resistance. Compared to the control, Ea1189-3(pBlueKS.acrD-ext) displayed increased resistance to clotrimazole (4-fold), fusidic acid (8-fold), novobiocin (16-fold), hygromycin B (2-fold), cadmium acetate (2-fold), zinc sulfate (2-fold), bile salt (8-fold), deoxycholate (8-fold), SDS (2-fold), luteolin (8-fold) and ethidium bromide (2-fold) (Table 1).

RND-type efflux pump expression during cellular growth

To monitor the expression levels of the RND-type efflux pumps AcrAB and AcrD at different growth states, total RNA was isolated at distinct optical densities and expression levels analyzed by quantitative RT-PCR. The expression values were normalized to the highest expression of the acrA and acrD transcript, respectively (Figure 1A). While the expression levels of acrA changed during the cell cycle, indicating a growth phase-dependent transcription with the highest expression in the early exponential phase, acrD showed constant expression during growth. Additionally, the constant expression of acrD was also connected to a low expression level as determined by Ct values (data not shown).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2180-14-13/MediaObjects/12866_2013_Article_2185_Fig1_HTML.jpg
Figure 1

Promoter activities of acrA and acrD from Erwinia amylovora. The activity was determined in the course of growth in LB broth, OD600, optical density at 600 nm. (A) Relative mRNA transcript abundance of acrA and acrD during cellular growth of Ea1189 as determined by quantitative RT-PCR. The relative mRNA level was related to the highest average value determined for a gene, which was defined as 100%. (B) Expression of acrA and acrD as determined by transcriptional fusions with the reporter gene egfp. E. amylovora wild type was transformed with pBBR.acrA-Pro.egfp and pBBR.acrD-Pro.egfp, respectively. Experiments were performed in triplicates with similar results.

Furthermore, we studied the effect of temperature on activation of the RND-type efflux pump AcrD using qRT-PCR. Bacteria were cultured in LB broth at 18°C and 28°C, respectively, where 28°C represents the optimal growth temperature and 18°C represents the temperature at which several genes involved in pathogenicity showed induction in E. amylovora[30, 31]. However, no temperature dependence of the acrD expression was observed in vitro (data not shown).

Promoter activity of acrAB and acrD in vitro

In order to monitor promoter activities of the RND-type efflux pumps AcrAB and AcrD in E. amylovora, transcriptional fusions of the acrA upstream region (140 bp) and acrD upstream region (210 bp), respectively, to the enhanced green fluorescence protein-encoding gene (egfp) were constructed. To determine whether bacterial growth influenced the promoter activity, fluorescence measurements at several optical densities were performed (Figure 1B). Our data indicated that the promoter activities of both acrAB and acrD were constant throughout the growth phases in LB broth. Furthermore, the activity of the acrD promoter was 4 to 5-fold lower than the activity of the acrAB promoter throughout growth.

Effect of substrate exposure on acrD expression

The expression of genes encoding multidrug efflux systems can be influenced by substrates, which interact with regulatory proteins and therefore increase gene transcription [32]. Above results prompted us to investigate whether antimicrobials affect the expression of the acrD gene in E. amylovora. Therefore, we utilized a transcriptional fusion between the promoter region of acrD and egfp (pBBR.acrD-Pro.egfp). In order to determine the promoter activity of acrD, we developed a screening assay in a 96-well-plate format. Antimicrobial compounds were added to the plasmid-harboring cells by the 2-fold dilution method and EGFP fluorescence was determined after 24 hours. Only fluorescence values from substrate concentrations that did not inhibit bacterial growth were plotted versus optical density on a scatter plot (see Additional file 5). Outliers, showing higher fluorescence than the remaining dataset, thus potential inducers of acrD expression, were identified as deoxycholate, naringenin, tetracycline and zinc sulfate. In the next step, the effect on the activity of the acrD promoter was evaluated in batch cultures. We included novobiocin and fusidic acid since they were identified as substrates of AcrD in E. coli[14, 33]. Additionally, we tested tannin because it displayed a 2-fold induction of acrD in qRT-PCR analysis (data not shown). After 24 hours incubation, the fluorescence signal was measured and normalized to an OD600 of 0.1 (Figure 2). The tested substrates were able to induce the acrD promoter by approximately 2 to 3-fold. Among the tested substrates, deoxycholate and zinc, showed significant differences in comparison to the control (P < 0.05).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2180-14-13/MediaObjects/12866_2013_Article_2185_Fig2_HTML.jpg
Figure 2

Promoter activity of acrD from Erwinia amylovora determined by transcriptional fusions with the reporter egfp . Fluorescence was determined 24 h after incubation of the bacteria with various transporter substrates. Substrates were added to a final concentration of 1:10 of the determined MIC values; deoxycholate (50 μg/ml), zinc sulfate (15.6 μg/ml), tetracycline (0.16 μg/ml), naringenin (31.2 μg/ml), novobiocin (1.2 μg/ml), fusidic acid (0.31 μg/ml) and tannin (500 μg/ml). The dotted line indicates the basal acrD promoter activity. Statistically significant differences (P < 0.05) are indicated by asterisks (*) and were determined by a two-sided t-test with equal variances. a.u., arbitrary units.

Contribution of AcrD to virulence of E. amylovora on apple rootstocks

To study the impact of AcrD on virulence of E. amylovora Ea1189, apple rootstocks MM 106 were infected and the development of disease symptoms was monitored. After one week of incubation all infected shoots showed typical disease symptoms including the shepherd’s crook-like bending of the shoot tip, tissue necrosis and ooze formation surrounding the infection site. Furthermore, bacterial populations were counted 1 and 5 day(s) post inoculation, respectively. However, no significant differences between the populations of the wild type and the mutant were observed (Table 2).
Table 2

Virulence assay on apple rootstock MM 106

Strain

Re-isolated bacterial cells a

 

1 dpi

5 dpi

Ea1189

2.5 × 106 ± 1.1 × 106

4.7 × 108 ± 1.1 × 108

Ea1189.acrD

6.1 × 106 ± 4.7 × 106

3.5 × 108 ± 1.1 × 108

a Bacteria were inoculated by prick technique in the shoot tips with an inoculum of 5 × 106 CFU/shoot. Establishment of a population of Erwinia amylovora Ea1189 and acrD mutant (CFU/shoot) was determined 1 and 5 days post inoculation (dpi), respectively.

Additionally, immature pear fruits were infected with the wild type and the acrD-deficient mutant and disease symptoms were monitored by means of the diameter of necrotic tissue surrounding the infection site (Figure 3). After 8 days of incubation, when the pear fruit was almost completely necrotic, no significant differences between the wild type and the mutant were observed.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2180-14-13/MediaObjects/12866_2013_Article_2185_Fig3_HTML.jpg
Figure 3

Virulence of Erwinia amylovora Ea1189 wild type and the acrD -deficient mutant on immature pear fruits. Symptoms were monitored starting from the 3rd day post inoculation (dpi) until the fruits were completely necrotic (around 8 dpi). Data values represent the means of 6 replicates ± standard deviation.

Transcriptional analysis of acrA and acrD of E. amylovora in planta

In order to analyze the acrA and acrD promoter activities in planta, Ea1189 was infected into shoot tips of apple rootstocks MM 106 as well as into immature pear fruits. Several hours (pears) and days (apple shoots), respectively, after inoculation bacteria were re-isolated by macerating infected plant areas. Total RNA was isolated from recovered cells and transcript abundances of acrA and acrD were determined by quantitative RT-PCR. RT-PCR signals of recovered bacteria were compared with RT-PCR signals of Ea1189 cells grown in LB broth to an OD600 of 0.5.

For immature pear infections, we first determined the expression of the sigma factor HrpL, which coordinates the transcription of genes of the hypersensitive response and pathogenicity (hrp) type III secretion system in E. amylovora, to identify the time of maximal expression of plant-inducible hrp genes. Compared to growth in LB broth, hrpL expression was 9-fold higher 6 h post inoculation into immature pears; after 12 h, expression was greatest (40-fold induction), and after 18 h, hrpL expression decreased again (10-fold induction). Hence, we investigated the expression of acrA and acrD genes with Ea1189 cells recovered from infected immature pear fruits 12 h after inoculation and compared them with cells grown in LB broth to an OD600 of 0.5 (Table 3). Our results indicated that neither acrA nor acrD are induced in the early infection phase of immature pear fruits.
Table 3

Relative fold-changes in mRNA transcripts of acrA and acrD after inoculation of Erwinia amylovora Ea1189 on apple rootstocks MM106 and immature pear fruit slices, respectively a

Gene

Apple rootstock

Immature pear

 

1 dpi b

4 dpi

7 dpi

12 hpi c

acrA

-6.9

-5.8

-10.4

1.2

acrD

3.9

3.5

3.6

1.1

a Total RNA was isolated from bacterial cells recovered from infected plant tissues. Transcript abundance of acrA and acrD was determined by quantitative RT-PCR and was compared to RT-PCR signal from cells grown in LB broth to an OD600 of 0.5.

b Bacteria were re-isolated from infected shoots of apple rootstock 1, 4 and 7 days post inoculation (dpi).

c Bacteria were re-isolated from infected immature pears 12 hours post inoculation (hpi).

For apple rootstock infections, bacteria were re-isolated 1, 4 and 7 days after inoculation, respectively, and compared the abundance of acrA and acrD transcripts with cells grown in LB broth (Table 3). Due to the high activity of the acrA promoter in LB broth, expression analysis by quantitative RT-PCR revealed a down regulation of this gene in planta. On the other hand, since acrD was only expressed at a low level during cellular growth in LB broth, it showed a more than 3-fold induction in planta.

Regulation of the RND-type multidrug efflux pump AcrD in E. amylovora

In other enterobacteria, e.g., E. coli and S. enterica, BaeR is involved in the regulation of the RND-type efflux pumps MdtABC and AcrD [19, 34]. BaeR is the response regulator of the two-component system BaeSR, which controls a small set of adaptive factors involved in a unique envelope stress response in E. coli[23]. A BLASTP search using the amino acid sequence of BaeR from E. coli K12 as the query identified a homologous sequence in the genome of E. amylovora CFBP1430 (GenBank:EAMY_2266). These homologues share 74% amino acid sequence identity with each other.

In order to test whether BaeR plays a role in the regulation of the acrD promoter in E. amylovora, we analyzed whether the published BaeR-binding site sequence motif from E. coli (5′-TTTTTCTCCATDATTGGC-3′) is present in the plant pathogen [35]. Indeed we identified a similar motif resembling the BaeR binding box located at position -166 to -148 bp upstream of the coding sequence of acrD in Ea1189: 5′-TTC TTCA CG ATT AC TGGC-3′ (bold letters indicate mismatches to the consensus sequence of E. coli).

To confirm the binding of BaeR to the acrD promoter in vitro, an electrophoretic mobility shift assay (EMSA) was performed. DNA fragments used in the EMSA were the Cy5-labeled upstream region of acrD (246 bp), and as controls, the upstream regions of acrAB (205 bp) and tolC (291 bp). The DNA fragments were incubated with increasing amounts of purified BaeR protein in presence of nonspecific competitor DNA (Salmon sperm) (Figure 4). The purified BaeR protein showed binding to the upstream region of acrD with increasing concentrations, which was detected as a smear (Figure 4A). A slight interaction between the acrAB promoter and BaeR was detected at the highest protein concentration (64 pM), which could suggest an unspecific binding (Figure 4B). No interactions between the fragment of the promoter region of tolC and BaeR were detected (Figure 4C). These results show that BaeR binds to the acrD regulatory region and is probably involved in its regulation.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2180-14-13/MediaObjects/12866_2013_Article_2185_Fig4_HTML.jpg
Figure 4

Electrophoretic mobility shift analysis of BaeR interaction with Cy5-labeled DNA fragments. DNA fragments contain the promoter regions of (A) acrD (246 bp), (B) acrA (205 bp) and (C) tolC (291 bp), respectively. Approximately 0.16 pmol of the DNA fragments were incubated with increasing amounts of His-tag purified BaeR (indicated at the top of each lane). The DNA-protein complexes were separated on 4% non-denaturing polyacrylamide gels.

Induction of acrD through overexpression of BaeR

Owing to the interaction between the acrD promoter region and BaeR observed during EMSA assays, we investigated whether overexpression of BaeR may induce the expression of acrD. Therefore, we cloned baeR under an arabinose-inducible promoter (pBAD24.baeR) and performed qRT-PCR analysis 1 hour after induction. Relative fold-changes in mRNA transcripts of acrA (0.8-fold), acrD (3.8-fold) and tolC (0.7-fold) were determined. The obtained data values correlate with the observed interaction of BaeR during EMSA indicating a specific binding of BaeR to the regulatory region of acrD.

Discussion

Bacteria have evolved energy-dependent multidrug efflux pumps in order to prevent intracellular accumulation of toxic compounds, including antimicrobials, antibiotics, dyes and detergents [6, 34]. In several enterobacteria, including the human pathogen E. coli and the plant pathogen E. amylovora, the RND transporter AcrAB-TolC has been described as the major multidrug efflux system providing resistance towards lipophilic and amphiphilic substrates but not towards hydrophilic compounds [6, 16]. Another member of the RND family, AcrD, has been shown to efficiently efflux highly hydrophilic aminoglycosides from E. coli cells [13]. Here, we identified a gene encoding AcrD in E. amylovora Ea1189, which shows significant sequence homology to the cognate aminoglycoside efflux pump of E. coli and investigated the role of this transporter in the fire blight pathogen.

Due to the high level of homology shared by AcrD from E. coli and E. amylovora, it was not surprising to find similar substrate specificities. Previous studies of AcrD in E. coli have characterized it as an efflux transporter which provides resistance to hydrophilic aminoglycosides as well as to some amphiphilic compounds such as bile acids, novobiocin and fusidic acid [14, 33]. It has also been reported that deletion of acrD does not cause hypersusceptibility to amphiphilic drugs [36, 37], which may be due to low expression levels during cellular growth [14]. We have been able to detect similar low expression levels of acrD in E. amylovora Ea1189 during growth in LB broth (Figure 1A). Moreover, we were unable to detect hypersusceptibility to any of the tested antimicrobial compounds in an acrD-deficient mutant (Table 1).

As noted for other bacteria, the overproduction of AcrD in an acrB-deficient host led to increased resistance towards detergents, novobiocin and fusidic acid [14, 35]. Overproduction of AcrD in an acrB-deficient mutant of E. amylovora Ea1189 increased the resistance to several antimicrobial compounds and heavy metals. It is noteworthy that expression of acrD under control of the lac promoter displayed only a minor effect on the resistance level compared to acrD expression driven by a combination of the lac promoter and the native promoter (up to 16-fold changes in MICs, Table 1). It has previously been reported that strong overproduction of AcrD may interfere with normal activity of the pump [14].

In this study, we identified two new substrates, clotrimazole and luteolin, which increased the substrate spectrum of AcrD in enterobacteria. Clotrimazole is a derivative of imidazole, commonly used in the treatment of fungal infections, and acts primarily by inhibiting the activity of cytochrome P450 mono-oxygenase [38]. Luteolin is one of the most common flavonoids present in many plant families. One of the functions of flavonoids in plants is their protective role against microbial invasion. Luteolin was shown to inhibit bacterial N-acetyltransferase activity [39].

Since AcrD conferred resistance to aminoglycosides in E. coli[13], we hypothesized that AcrD of E. amylovora would display a similar substrate spectrum. However, overexpression of AcrD in E. amylovora Ea1189-3 did not increase the MICs of the aminoglycosides amikacin, gentamicin, streptomycin, and tobramycin. Although it is important to note that we observed occasional, but not reproducible, 2-fold differences between the aminoglycoside MICs for different experiments (data not shown). While this result is contradictory to previous findings for E. coli[13], it may reflect a possible adaptation of the AcrD transporter to a particular physiological function during growth in the plant environment.

To elucidate the role of AcrD in the plant environment, we analyzed whether this RND-type efflux pump is involved in pathogenesis of the plant pathogen. Previously, we have observed that disruption of the AcrB efflux pump in E. amylovora significantly reduced virulence on apple rootstock [16]. This prompted us to evaluate the effect of AcrD on the virulence of the fire blight pathogen by studying development of disease symptoms. However, one week after inoculation, the wild type as well as the acrD-deficient mutant conferred typical symptoms on all inoculated shoots, indicating that the disruption of the efflux pump had negligible impact on virulence on apple rootstock. As the host range of E. amylovora also includes pear trees, we further investigated the virulence of the wild type and its acrD-deficient mutant on immature pear fruits (cv. ‘Bartlet’) with the conclusion that AcrD is not involved in the interaction of the fire blight pathogen with this host.

Additionally, we studied the expression levels of the AcrAB and AcrD efflux pumps in vitro and in planta, respectively. The activity of the acrA promoter was lower in planta than in LB medium (Table 3). However, it is possible that growth of the bacteria in LB broth may increase expression of the AcrAB pump. A similar induction of the RND-type efflux system MexAB-OprM in Pseudomonas syringae was observed during growth in complex King’s B medium [40]. Specific components of the complex media might induce the expression of these RND efflux systems. Alternatively, the efflux pumps may play a role in the secretion of metabolites during exponential growth of bacteria in complex medium.

The level of acrD expression was low during growth in LB medium (Figure 1B), whereas it was slightly induced in planta (Table 3) indicating that plant-derived compounds are able to induce the AcrD pump. The nature of these compounds remains to be elucidated.

Several multidrug transporters are induced in response to the presence of toxic substances [18]. We identified the substrates deoxycholate, naringenin, tetracycline, novobiocin, fusidic acid, tannin and zinc as inducers of acrD in E. amylovora. In prokaryotes, the expression of drug transporter genes is frequently mediated by transcriptional regulatory proteins, whose genes are often located adjacent to those encoding the transport system. However, no local transcriptional regulator was identified flanking the acrD gene in E. amylovora, suggesting that expression of acrD may be subject to regulation at the global level.

The acrD gene belongs to the regulon of the envelope stress response, two-component system BaeSR in E. coli and Salmonella enterica. A baeSR-deficient mutant of E. amylovora Ea1189 has previously been evaluated for virulence on immature pears, and exhibit full-virulence, as that of wild type, on immature pear fruits [41]. The core regulon of BaeSR consists of spy, encoding a protein chaperon, and the RND efflux pump genes acrD and mdtABC[42]. Interestingly, we identified a partial overlap between the compounds inducing expression of acrD in E. amylovora and baeR in E. coli, e.g., flavonoids (naringenin), zinc, and tannin [24, 42]. Accordingly, the contribution of the two-component system BaeSR to regulation of the acrD gene in E. amylovora became of particular interest to us. In E. coli and S. enterica, BaeR, upon activation by phosphorylation through BaeS, binds to the upstream promoter region of mdtA and acrD[19, 35]. Our results showed that BaeR of E. amylovora is able to bind the promoter region of acrD in E. amylovora, but not to the promoter regions of acrA or tolC (Figure 4). Additional investigation of the regulatory networks controlling expression of acrD in growth cultures and in natural environments, such as within host plants, will need to be conducted in order to provide further insights into the role of this multidrug transporter in the physiology of the cell.

In summary, we have identified a homologue of the RND-type multidrug efflux pump AcrD in E. amylovora Ea1189. Despite the fact that AcrD of Ea1189 was unable to efflux aminoglycosides, we detected a similar substrate spectrum compared to homologues of AcrD from other enterobacteria. Finally, we identified two substrates, clotrimazole and luteolin, hitherto unreported as substrates of AcrD in E. coli and S. enterica.

Conclusions

The aim of the present study was the characterization of AcrD, a RND-type multidrug efflux pump from the plant pathogen E. amylovora, causing fire blight on apple and pear. Our results demonstrated that AcrD plays a role in drug resistance to a limited number of amphiphilic compounds. We showed that the substrate specificity of AcrD from E. amylovora and of AcrD from E. coli is partly overlapping. However, in contrast to AcrD from E. coli, AcrD from E. amylovora cannot provide resistance towards aminoglycosides. The expression of acrD was up-regulated by the addition of several substrates and was found to be regulated by the envelope stress two-component regulatory system BaeSR. An acrD mutant showed full virulence on apple rootstock and immature pear fruits.

Methods

Bacterial strains, plasmids and growth conditions

Bacterial strains and plasmids used in this study are listed in Table 4. E. amylovora strains were cultured at 28°C in Lysogeny Broth (LB) or on LB plates. E. coli XL-1 Blue was used as cloning host. E. coli cells were routinely maintained at 37°C in LB or double Yeast Trypton (dYT) medium. Cultures harboring individual vectors were supplemented with 50 μg/ml ampicillin (Ap) for E. coli or 250 μg/ml for E. amylovora, 25 μg/ml chloramphenicol (Cm), 2 μg/ml gentamicin (Gm) and 25 μg/ml kanamycin (Km) when necessary. Bacterial growth was monitored using a spectrophotometer at 600 nm (OD600).
Table 4

Bacterial strains and plasmids used in this study

Plasmid or strain

Relevant characteristics or genotype a

Reference or source

Plasmid

  

pJET1.2

Apr, rep (pMB1) from pMBI responsible for replication

Thermo scientific

pCAM-MCS

Apr, pCAM140-derivative without mini-Tn5, contains the MCS of pBluescript II SK (+)

[16]

pFCm1

Apr, Cmr, source of Cmr cassette flanked by FRT sequences

[43]

pCAM-Km

Kmr, variant of the gene replacement vector pCAM-MCS, Apr replaced by Kmr

This study

pCAM-Km.acrD-Cm

Kmr, Cmr, contains a 1.1-kb fragment of acrD from E. amylovora Ea1189, insertion of 1153-bp Cm-FRT cassette from pFCm1 in BamHI site

This study

pBlueScript II SK(+)

Apr, ColE1 origin

Stratagene

pBlueScript II KS(+)

Apr, ColE1 origin

Stratagene

pBBR1MCS

Cmr, ColE1 origin

[44]

pBlueKS.acrD

Apr, contains a 3.1-kb fragment carrying acrD of E. amylovora Ea1189 under control of lac promoter

This study

pBlueKS.acrD-ext

Apr, contains a 3.5-kb fragment carrying acrD of E. amylovora Ea1189 including promoter region under control of lac promoter

This study

pBlueSK.acrD

Apr, contains a 3.1-kb fragment carrying acrD of E. amylovora Ea1189 in opposite orientation with respect to lac promoter

This study

pBlueSK.acrD-ext

Apr, contains a 3.5-kb fragment carrying acrD of E. amylovora Ea1189 including promoter region in opposite orientation with respect to lac promoter

This study

pBBR.egfp.TIR

Cmr, contains the TIR-egfp-T0 cassette in pBBR1MCS in opposite orientation with respect to lac promoter

[16]

pBBR.acrD-Pro.egfp

Cmr, contains a 206-bp fragment carrying the promoter region of acrD, transcriptional fusion of acrD with egfp

This study

pBBR.acrA-Pro.egfp

Cmr, contains a 133-bp fragment carrying the promoter region of acrA, transcriptional fusion of acrA with egfp

This study

pBlueSK.baeR

Apr, contains a 0.7-kb fragment carrying baeR of E. amylovora Ea1189 under control of lac promoter

This study

pET-28a(+)

Kmr, f1 origin

Novagen

pET28a.baeR

Kmr, contains a 0.7-kb fragment carrying baeR of E. amylovora Ea1189, C-terminal translational fusion with His-tag

This study

pCP20

Cmr, Apr, contains yeast Flp recombinase gene, rep (pSC101) responsible for temperature-sensitive replication

[45]

pBAD24

Apr, pMB1 origin, araC

[46]

pBAD24.baeR

Apr, contains a 0.7-kb fragment carrying baeR of E. amylovora Ea1189 under control of PBAD promoter

This study

Strain

  

Escherichia coli

  

XL1-Blue

endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK - mK +)

Stratagene

TG1

K-12 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, (rK -mK -)

[47]

KAM3

acrAB mutant of TG1

[48]

BL21(DE3)

F ompT gal dcm lon hsdSB(rB - mB -) (λDE3)

Novagen

S17-1

TpR SmR recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: Km

[49]

S17-1 λ-pir

λpir phage lysogen of S17-1

[49]

DH5α λ-pir

sup E44, ΔlacU169 (ΦlacZΔM15), recA1, endA1, hsdR17, thi-1, gyrA96, relA1, λpir phage lysogen

D. Lies, Caltech

Erwinia amylovora

  

Ea1189

Wild type

GSPB b

Ea1189-3

Kmr, acrB mutant carrying Kmr cassette in the acrB gene

[16]

Ea1189.acrD

acrD mutant

This study

a Apr, ampicillin resistance; Cmr, chloramphenicol resistance; Kmr, kanamycin resistance.

b GSPB, Göttinger Sammlung Phytopathogener Bakterien, Göttingen, Germany.

PCR amplifications, modifications and protein purification

Primers (see Additional file 6) were designed based on E. amylovora CFBP1430 genome sequences available from NCBI (GenBank NC_013961.1). Screening PCR reactions were carried out using the DreamTaq DNA polymerase (Thermo Scientific) in accordance with the manufacturer’s instructions and optimized annealing temperatures based on the melting temperatures of the respective primers. For high fidelity PCR reactions, Phusion DNA polymerase (Thermo Scientific) was used where the annealing temperature was 3°C higher than the lower temperature of the used primer combination.

Restriction enzyme (Thermo Scientific) and T4 DNA ligase (Thermo Scientific) reactions were performed as per the manufacturer’s instructions at the appropriate temperature where all ligation reactions were incubated at room temperature.

DNA purifications were either performed using the GeneJET PCR purification kit (Thermo Scientific) or the GeneJET Gel extraction kit (Thermo Scientific) following the manufacturer’s instructions.

Protein purification was carried out using the Ni-NTA Spin Kit (Qiagen) following the manufacturer’s instructions.

Construction of the E. amylovora acrD-deficient mutant

A 1058-bp fragment located in the acrD gene was amplified using the primer pair acrD_ko_fwd and acrD_ko_rev and verified by sequencing. A chloramphenicol cassette flanked by Flp-FRT sites was cut from plasmid pFCM1 and inserted into Bam HI-digested pJET.acrD-ko, yielding pJET.acrD-ko.Cm. A 2.2-kb Eco RI fragment cut from pJET.acrD-ko.Cm was ligated into Eco RI-digested pCAM-Km, yielding the final replacement plasmid pCAM-Km.acrD-Cm. The plasmid was transformed into electrocompetent cells of E. amylovora Ea1189, which subsequently were grown for 3 h at 28°C in dYT broth. Putative mutants were screened for homologous recombination events by testing their antibiotic resistance. Mutants that resulted from single crossover events were identified by their ability to grow on plates containing Km. In order to confirm gene disruption through a double crossover event in Cm-resistant and Km-sensitive colonies, primers acrD_fwd and acrD_rev were designed, which bind upstream and downstream, respectively, of the 1058-bp acrD fragment used for generation of the gene replacement vector. PCRs were done using these locus-specific primers with primers binding in the Cm cassette (cat_out2, cat_out3, cat_out4, cat_out5). Amplified PCR products were verified by sequencing.

The Cm-FRT cassette was finally excised using the temperature-sensitive plasmid pCP20 that carries the yeast Flp recombinase gene [43, 45]. Briefly, Cm-resistant mutants of Ea1189 were transformed with pCP20 and selected at 28°C on LB plates containing Ap. Subsequently, Ap-resistant transformants were streaked on non-selective agar plates and incubated at 43°C for 1 h; following incubation at 28°C for 48–60 h. Single colonies were selected and tested on agar plates containing Cm or Ap to confirm successful excision of the Cm cassette and loss of plasmid pCP20.

Construction of acrD overexpression plasmids

A 3.06-kb fragment containing acrD was amplified from E. amylovora Ea1189 using the primer pair acrD-ApaI and acrD-SacI. The PCR product was sequenced and further cloned into Apa I-Sac I-digested pBlueScript II KS(+) and pBlueScript II SK(+), respectively (pBlueKS.acrD, pBlueSK.acrD).

Next, a 210-bp fragment containing the upstream region of acrD was amplified using the primers narP-ApaI and acrD_SalI. The PCR product was cloned into a Sal I restriction site located in the beginning of the acrD gene (pBlueKS.acrD-ext, pBlueSK.acrD-ext).

Drug susceptibility tests

The minimal inhibitory concentrations (MIC) of drugs for E. amylovora strains were determined by a 2-fold dilution assay in Mueller-Hinton broth (MHB). All tests were done in at least triplicate following the Clinical and Laboratory Standards Institute recommendations [50]. Growth of bacteria at 28°C was examined by visual inspection after 48 h incubation. The MIC was defined as the lowest concentration of an antibiotic that completely prevented visible cell growth.

Generation of promoter-EGFP fusions

Transcriptional fusions between the promoter regions of acrA and acrD, respectively, and egfp were created using a previously described PCR-based method [51]. Briefly, a 546-bp fragment containing the upstream region of acrD was amplified using the primer acrD_up and the reverse primer acrD-P-egfp containing a 24-nt extension that is homologous to the start of the egfp gene. The acrA upstream region was amplified using the primer acrAB_fwd and the reverse primer acrA-P-egfp. Next, the reporter gene egfp was amplified using the primer pair egfp-ATG and egfp-Cm and the plasmid pBBR.egfp.TIR [16] as the template. All PCR products were gel-purified. For the fusion reaction, 200 ng of a PCR fragment containing a promoter region were mixed with 200 ng of the reporter gene fragment. Nested primer pairs were used for the fusion PCR reactions. For fusion of the acrD promoter to the egfp gene, the primers acrD-P-fwd_SacII-2 and uidA-t0-KpnI were used. The primers acrA-P-fwd-SacII and uidA-t0-KpnI were used in a PCR to fuse the acrA promoter to egfp. The PCR products were gel-purified to remove non-fused fragments. Next, the fusion product was cloned in opposite direction to the lacZ’ promoter, into Sac II-Kpn I-treated pBBR1MCS, yielding plasmids pBBR.acrA-Pro.egfp and pBBR.acrD-Pro.egfp.

Promoter activity of acrD in vitro

The reporter gene egfp was employed to study the impact of diverse antimicrobial substances on promoter activities of acrD in E. amylovora. Plasmids carrying the transcriptional fusions were transformed into Ea1189. Antimicrobial compounds were added to the bacterial cells in 96-well microtiter plates by the 2-fold dilution method as described for MIC assays. EGFP fluorescence of the cells following exposure to various concentrations of the substrates was measured 48 hours after incubation at 28°C using the microplate reader Infinite M1000 PRO (Tecan, Crailsheim, Germany) with an excitation wavelength of 470 nm and emission detection at 516 nm.

Fluorescence values obtained were plotted versus optical density in a scatter plot (see Additional file 5). A best-fit linear regression line was added to the plot and a 95% confidence interval determined. Data points that did not meet the confidence interval criteria indicate fluorescence values higher than the average, thereby suggesting induction of the acrD promoter by the respective compound.

To further demonstrate promoter induction, the identified substrates were tested in liquid cultures. Cells of Ea1189 harboring plasmid pBBR.acrD-Pro.egfp were incubated in LB broth supplemented with each substrate for 24 hours, then harvested by centrifugation, resuspended in phosphate-buffered saline, adjusted to an OD600 value of 0.1 and fluorescence determined.

Apple plant material and inoculation procedures

Apple plants (rootstock Malus MM106) were grown in a greenhouse at 20 to 25°C, 60% humidity, and 12 h photoperiod (15,000 lx). E. amylovora Ea1189 and its acrD mutant, grown on LB agar for 24 h, were resuspended and diluted to a cell density of 1 x 106 CFU/ml in sterile demineralized water. Apple plants were inoculated by prick technique [52]. Each bacterial strain was inoculated into one shoot of five single plants. A bacterial suspension (5 μl) was placed onto each wound on the shoot tip. Plants were monitored for symptom development daily. Survival of bacteria in plant tissue was examined by re-isolation of bacterial cells 1 and 5 day(s) after inoculation, respectively, from 1 cm of the shoot tip around the inoculation area. Ultimately, five wounds were pooled together, homogenized in 0.9% NaCl, serially diluted, and spread on LB agar plates. The experiment was repeated in triplicate.

In order to analyze the abundance of acrA and acrD mRNA transcripts in E. amylovora Ea1189 during growth in apple rootstock MM106, total RNA was isolated from infected apple shoots 1, 4 and 7 day(s) post inoculation, respectively. Five individual wounds were pooled together, homogenized in 0.9% NaCl and centrifuged for 2 min at 4000 rpm. The supernatant was transferred to 15 ml killing buffer (20 mM Tris–HCl, pH 7.5; 20 mM NaN3) [53] and centrifuged for 20 min at 4000 rpm. The supernatant was decanted and the pellet frozen at -80°C for further RNA extraction.

Virulence assay on immature pears

Virulence of E. amylovora Ea1189 and its acrD mutant was determined on immature pears (cv. ‘Bartlet’). Bacteria, grown at 28°C on LB agar plates for 24 h, were resuspended and adjusted to an OD600 of 1.0 in sterile demineralized water for inoculation. Immature pear fruits were surface-sterilized and pricked with a sterile needle as described previously [54]. Wounds were inoculated with 5 × 106 CFU/ml and incubated in a humidified chamber at room temperature for 8 days. Disease symptoms were recorded by means of diameter of necrosis surrounding the infection site. Fruits were assayed in triplicates and the experiment was repeated twice.

To analyze gene expression of E. amylovora Ea1189 during growth on pear fruits, immature fruits were cut in slices (approx. 0.5 cm). Five slices were inoculated with 100 μl of a bacterial suspension adjusted to an OD600 of 1.0 in sterile demineralized water. The suspension was evenly distributed on the slice and incubated for 12 hours in a humidified chamber at room temperature. Next, the upper layer of the surface was scratched from the five slices, resuspended in 25 ml of PBS and centrifuged for 2 min at 4000 rpm. The supernatant was transferred to 15 ml killing buffer and further processed as described above.

RNA isolation and quantitative real-time PCR

Cell cultures were grown in LB broth until the desired optical densities were achieved. An aliquot containing 15 × 109 CFU (equivalent of 15 ml OD600 of 1.0) was transferred to 15 ml killing buffer and centrifuged for 20 min at 4000 rpm. The supernatant was decanted and the pellet frozen at -80°C for further RNA extraction.

Total RNA was isolated by acid phenol/chloroform extraction [53]. The obtained RNA was treated with DNAse (Ambion/Life Technologies, Darmstadt, Germany) and subsequently checked for purity by gel electrophoresis and determination of the A260/A280 and A260/A230 ratios using a Nanodrop ND-2000 spectrophotometer (Thermo Fischer Scientific). High quality RNA was reverse transcribed and amplified with the OneStep RT-PCR Kit according to the manufacturer’s protocol (Qiagen, Hilden, Germany). Template RNA (5 ng) was used in a standard 25-μl qRT-PCR reaction with specific primers (see Additional file 6). As negative control, RNA samples without reverse transcriptase were included to detect possible DNA contaminations.

For analysis, a Mastercycler ep realplex 2 gradient S (Eppendorf, Hamburg, Germany) was used. Cycling parameters included a 15 min initial denaturation at 95°C to activate the DNA polymerase followed by 40 cycles consisting of 15 sec at 95°C, 30 sec at 55°C and 30 sec at 72°C. The final step consisted of 1 min at 95°C and 30 sec at 55°C. A melting curve analysis with a temperature ramp from 25°C to 95°C in 20 min was performed at the end of each run to determine specificity of amplified qPCR products.

Each sample was analyzed for gene expression in triplicate. Quantification of mRNA transcripts was performed by the comparative Ct method. Briefly, the Ct values of the samples of interest were compared with a non-treated sample. All Ct values were normalized to the housekeeping gene recA, which shows constant expression at different ODs and medium compositions as well as similar amplification efficiency to the target genes [55]. The comparative Ct method was calculated by 2 - Δ C t , sample - Δ C t , reference , where ΔCt was normalized to the endogenous housekeeping gene recA. Subsequently, fold-changes between the samples were determined based on the calculated Ct method.

Expression of the BaeR protein

Expression of BaeR was achieved by using the vector pBAD24 where the expression is controlled by the PBAD promoter and araC. Therefore, we cloned baeR under control of the arabinose inducible promoter (pBAD24.baeR) and transformed the plasmid into E. amylovora wild-type cells. Protein expression was induced by adding 1% L-arabinose when cultures reached an OD600 of 0.5. Cells were further incubated for 1 hour at 28°C and subsequently harvested by centrifugation.

Electrophoretic mobility shift assay

DNA fragments used for the electrophoretic mobility shift assay (EMSA) were PCR amplified using Cy5-labeled primers to perform a non-radioactive EMSA. DNA fragments used were the upstream region of acrD (246 bp), and as controls, the upstream regions of acrAB (205 bp) and tolC (291 bp). Approximately 0.16 pmol of Cy5-labeled DNA was mixed with increasing concentrations of His-tagged BaeR protein in a binding buffer reaction (50 mM Tris–HCl, pH 7.5; 1 mM DTT; 500 mM MgCl2; 100 mM EDTA; 10 mM NaCl; 5% glycerol). To decrease unspecific binding, 500 ng competitor DNA (Salmon sperm DNA, AppliChem) was added to the reaction. Incubation was done at room temperature for 30 min. The total reaction was run on a native 4% polyacrylamide gel in 0.5x Tris-borate-EDTA (TBE) buffer at constant 25 mA. After electrophoresis, fluorescence signals of the labeled DNA were visualized using a FLA-3000 phosphorimager (Raytest, Straubenhardt, Germany).

Statistical analysis

Statistical analysis was performed using R [56]. Differences between two groups were determined by a two-sided t-test with equal variances and were considered significant at P < 0.05. When necessary the standard deviation is presented in the graph when the average of several values was applied.

Declarations

Acknowledgments

This study was supported by Jacobs University Bremen and by the MOLIFE Research Center, Jacobs University Bremen.

Authors’ Affiliations

(1)
School of Engineering and Science, Jacobs University Bremen

References

  1. Vanneste J: Fire blight: The disease and its causative agent, Erwinia amylovora. 2000, Oxon, UK: CABI PublishingView ArticleGoogle Scholar
  2. Bubán T, Orosz-Kovács ZS, Farkas Á: The nectary as the primary site of infection by Erwinia amylovora (Burr.). Plant Syst Evol. 2003, 238: 183-194.Google Scholar
  3. Vanneste J, Eden-Green S: Migration of Erwinia amylovora in host plant tissues. Fire blight: the disease and its causative agent, Erwinia amylovora. 2000, Oxon, UK: CABI PublishingView ArticleGoogle Scholar
  4. Bonn WG, Van der Zwet T: Distribution and economic importance of fire blight. Fire blight: the disease and its causative agent, Erwinia amylovora. 2000, Oxon, UK: CABI Publishing, 37-53.View ArticleGoogle Scholar
  5. McManus PS, Stockwell VO, Sundin GW, Jones AL: Antibiotic use in plant agriculture. Annu Rev Phytopathol. 2002, 40: 443-465. 10.1146/annurev.phyto.40.120301.093927.View ArticlePubMedGoogle Scholar
  6. Nikaido H: Multidrug efflux pumps of gram-negative bacteria. J Bacteriol. 1996, 178: 5853-5859.PubMed CentralPubMedGoogle Scholar
  7. Walsh C: Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000, 406: 775-781. 10.1038/35021219.View ArticlePubMedGoogle Scholar
  8. Piddock LJ: Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol. 2006, 4: 629-636. 10.1038/nrmicro1464.View ArticlePubMedGoogle Scholar
  9. Pos K: Trinity revealed: Stoichiometric complex assembly of a bacterial multidrug efflux pump. Proc Natl Acad Sci U S A. 2009, 106: 6893-6894. 10.1073/pnas.0902837106.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Nakamura H: Gene-controlled resistance to acriflavine and other basic dyes in Escherichia coli. J Bacteriol. 1965, 90: 8-14.PubMed CentralPubMedGoogle Scholar
  11. Nikaido H: Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis. 1998, 27 (Suppl 1): S32-S41.View ArticlePubMedGoogle Scholar
  12. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE: Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 1993, 175: 6299-6313.PubMed CentralPubMedGoogle Scholar
  13. Rosenberg EY, Ma D, Nikaido H: AcrD of Escherichia coli is an aminoglycoside efflux pump. J Bacteriol. 2000, 182: 1754-1756. 10.1128/JB.182.6.1754-1756.2000.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Elkins CA, Nikaido H: Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol. 2002, 184: 6490-6498. 10.1128/JB.184.23.6490-6499.2002.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Poole K, Krebes K, McNally C, Neshat S: Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol. 1993, 175: 7363-7372.PubMed CentralPubMedGoogle Scholar
  16. Burse A, Weingart H, Ullrich MS: The phytoalexin-inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora. Mol Plant-Microbe Interact. 2004, 17: 43-54. 10.1094/MPMI.2004.17.1.43.View ArticlePubMedGoogle Scholar
  17. Al-Karablieh N, Weingart H, Ullrich MS: Genetic exchange of multidrug efflux pumps among two enterobacterial species with distinctive ecological niches. Int J Mol Sci. 2009, 10: 629-645. 10.3390/ijms10020629.PubMed CentralView ArticlePubMedGoogle Scholar
  18. Grkovic S, Brown MH, Skurray RA: Regulation of bacterial drug export systems. Microbiol Mol Biol Rev. 2002, 66: 671-701. 10.1128/MMBR.66.4.671-701.2002.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Nishino K, Honda T, Yamaguchi A: Genome-wide analyses of Escherichia coli gene expression responsive to the BaeSR two-component regulatory system. J Bacteriol. 2005, 187: 1763-1772. 10.1128/JB.187.5.1763-1772.2005.PubMed CentralView ArticlePubMedGoogle Scholar
  20. West AH, Stock AM: Histidine kinases and response regulator proteins in two-component signaling systems. Trends Biochem Sci. 2001, 26: 369-376. 10.1016/S0968-0004(01)01852-7.View ArticlePubMedGoogle Scholar
  21. Parkinson JS: Signal transduction schemes of bacteria. Cell. 1993, 73: 857-871. 10.1016/0092-8674(93)90267-T.View ArticlePubMedGoogle Scholar
  22. Hoch JA, Varughese KI: Keeping signals straight in phosphorelay signal transduction. J Bacteriol. 2001, 183: 4941-4949. 10.1128/JB.183.17.4941-4949.2001.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Raffa RG, Raivio TL: A third envelope stress signal transduction pathway in Escherichia coli. Mol Microbiol. 2002, 45: 1599-1611. 10.1046/j.1365-2958.2002.03112.x.View ArticlePubMedGoogle Scholar
  24. Leblanc SK, Oates CW, Raivio TL: Characterization of the induction and cellular role of the BaeSR two-component envelope stress response of Escherichia coli. J Bacteriol. 2011, 193: 3367-3375. 10.1128/JB.01534-10.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Livingstone CD, Barton GJ: Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. Comput Appl Biosci. 1993, 9: 745-756.PubMedGoogle Scholar
  26. Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ: Jalview Version 2 - a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009, 25: 1189-1191. 10.1093/bioinformatics/btp033.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Sievers F, Wilm A, Dineen DG, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins D: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011, 7: 539-PubMed CentralView ArticlePubMedGoogle Scholar
  28. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S, Paern J, Lopez R: A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 2010, 38: W695-W699. 10.1093/nar/gkq313.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Bernsel A, Viklund H, Hennerdal A, Elofsson A: TOPCONS: consensus prediction of membrane protein topology. Nucleic Acids Res. 2009, 37: W465-W468. 10.1093/nar/gkp363.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Goyer C, Ullrich MS: Identification of low-temperature-regulated genes in the fire blight pathogen Erwinia amylovora. Can J Microbiol. 2006, 52: 468-475. 10.1139/w05-153.View ArticlePubMedGoogle Scholar
  31. Wei ZM, Sneath BJ, Beer SV: Expression of Erwinia amylovora hrp genes in response to environmental stimuli. J Bacteriol. 1992, 174: 1875-1882.PubMed CentralPubMedGoogle Scholar
  32. Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P: Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev. 2007, 20: 79-114. 10.1128/CMR.00015-06.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Nishino K, Yamaguchi A: Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol. 2001, 183: 5803-5812. 10.1128/JB.183.20.5803-5812.2001.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Fernández L, Hancock RE: Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012, 25: 661-681. 10.1128/CMR.00043-12.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Nishino K, Nikaido E, Yamaguchi A: Regulation of multidrug efflux systems involved in multidrug and metal resistance of Salmonella enterica serovar Typhimurium. J Bacteriol. 2007, 189: 9066-9075. 10.1128/JB.01045-07.PubMed CentralView ArticlePubMedGoogle Scholar
  36. Ma D, Cook DN, Hearst JE, Nikaido H: Efflux pumps and drug resistance in Gram-negative bacteria. Trends Microbiol. 1994, 2: 489-493. 10.1016/0966-842X(94)90654-8.View ArticlePubMedGoogle Scholar
  37. Sulavik MC, Houseweart C, Cramer C, Jiwani N, Murgolo N, Greene J, DiDomenico B, Shaw KJ, Miller GH, Hare R, Shimer G: Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother. 2001, 45: 1126-1136. 10.1128/AAC.45.4.1126-1136.2001.PubMed CentralView ArticlePubMedGoogle Scholar
  38. McLean KJ, Marshall KR, Richmond A, Hunter IS, Fowler K, Kieser T, Gurcha SS, Besra GS, Munro AW: Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology. 2002, 148: 2937-2949.View ArticlePubMedGoogle Scholar
  39. Chung JG, Hsia TC, Kuo HM, Li YC, Lee YM, Lin SS, Hung CF: Inhibitory actions of luteolin on the growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from ulcer patients. Toxicol In Vitro. 2001, 15: 191-198. 10.1016/S0887-2333(01)00015-7.View ArticlePubMedGoogle Scholar
  40. Stoitsova SO, Braun Y, Ullrich MS, Weingart H: Characterization of the RND-type multidrug efflux pump MexAB-OprM of the plant pathogen Pseudomonas syringae. Appl Environ Microbiol. 2008, 74: 3387-3393. 10.1128/AEM.02866-07.PubMed CentralView ArticlePubMedGoogle Scholar
  41. Zhao Y, Wang D, Nakka S, Sundin GW, Korban SS: Systems level analysis of two-component signal transduction systems in Erwinia amylovora: role in virulence, regulation of amylovoran biosynthesis and swarming motility. BMC Genomics. 2009, 10: 245-10.1186/1471-2164-10-245.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Zoetendal EG, Smith AH, Sundset MA, Mackie RI: The BaeSR two-component regulatory system mediates resistance to condensed tannins in Escherichia coli. Appl Environ Microbiol. 2008, 74: 535-539. 10.1128/AEM.02271-07.PubMed CentralView ArticlePubMedGoogle Scholar
  43. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP: A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene. 1998, 212: 77-86. 10.1016/S0378-1119(98)00130-9.View ArticlePubMedGoogle Scholar
  44. Kovach ME, Phillips RW, Elzer PH, Roop RM, Peterson KM: pBBR1MCS: a broad-host-range cloning vector. Biotechniques. 1994, 16: 800-802.PubMedGoogle Scholar
  45. Cherepanov PP, Wackernagel W: Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene. 1995, 158: 9-14. 10.1016/0378-1119(95)00193-A.View ArticlePubMedGoogle Scholar
  46. Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose pBAD promoter. J Bacteriol. 1995, 177: 4121-4130.PubMed CentralPubMedGoogle Scholar
  47. Sambrook J, Russell DW: Molecular cloning: a laboratory manual. 2001, Cold Spring Harbor Press: Cold Spring HarborGoogle Scholar
  48. Morita Y, Kodama K, Shiota S, Mine T, Kataoka A, Mizushima T, Tsuchiya T: NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother. 1998, 42: 1778-1782.PubMed CentralPubMedGoogle Scholar
  49. Wilson KJ, Sessitsch A, Corbo JC, Giller KE, Akkermans AD, Jefferson RA: β-Glucuronidase (GUS) transposons for ecological and genetic studies of rhizobia and other gram-negative bacteria. Microbiology. 1995, 141: 1691-1705. 10.1099/13500872-141-7-1691.View ArticlePubMedGoogle Scholar
  50. Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 9th ed. 2012, Wayne, PA: CLSI document M7-A7Google Scholar
  51. Hobert O: PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. Biotechniques. 2002, 32: 728-730.PubMedGoogle Scholar
  52. May R, Völksch B, Kampmann G: Antagonistic activities of epiphytic bacteria from soybean leaves against Pseudomonas syringae pv. glycinea in vitro and in planta. Microb Ecol. 1997, 34: 118-124. 10.1007/s002489900041.View ArticlePubMedGoogle Scholar
  53. Schenk A, Weingart H, Ullrich MS: Extraction of high-quality bacterial RNA from infected leaf tissue for bacterial in planta gene expression analysis by multiplexed fluorescent Northern hybridization. Mol Plant Pathol. 2008, 9: 227-235. 10.1111/j.1364-3703.2007.00452.x.View ArticlePubMedGoogle Scholar
  54. McGhee GC, Jones AL: Complete nucleotide sequence of ubiquitous plasmid pEA29 from Erwinia amylovora strain Ea88: gene organization and intraspecies variation. Appl Environ Microbiol. 2000, 66: 4897-4907. 10.1128/AEM.66.11.4897-4907.2000.PubMed CentralView ArticlePubMedGoogle Scholar
  55. Takle GW, Toth IK, Brurberg MB: Evaluation of reference genes for real-time RT-PCR expression studies in the plant pathogen Pectobacterium atrosepticum. BMC Plant Biol. 2007, 7: 50-10.1186/1471-2229-7-50.PubMed CentralView ArticlePubMedGoogle Scholar
  56. Hornik K: R: A language and environment for statistical computing. 2013, Vienna, Austria: R Foundation for Statistical ComputingGoogle Scholar
  57. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B: Artemis: sequence visualization and annotation. Bioinformatics. 2000, 16: 944-945. 10.1093/bioinformatics/16.10.944.View ArticlePubMedGoogle Scholar

Copyright

© Pletzer and Weingart; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement